About this trial

Multiple sclerosis (MS) is a common inflammatory demyelinating disorder of the central nervous system frequently affecting females in their reproductive phase of life. In this prospective observational study, we obtain data on the outcome of pregnancies in MS patients and the influence of pregnancy on clinical, laboratory and MRI parameters in MS.

Eligibility criteria

Qualifiers

age > 18 years

signed informed consent

diagnosis of multiple sclerosis or clinically isolated syndrome

Disqualifiers

clinically relevant comorbidities

contraindications for MRI, e.g. pacemaker, metal implants, allergy against gadolinium

alcohol or drug abuse

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

100 Participants
are grouped into 1 trial group

Locations

1
Charité Universitätsmedizin Berlin13125, Berlin Germany

Sponsors and collaborators

Charite University, Berlin, Germany

Lead sponsor